week seven Flashcards

1
Q

Pre/Peri-menopause sx

A

Cycle irregularity (shortening then lengthening)
Increasing menopausal sx
Can last 3-8 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cessation of menses for _____ = menopause

A

1 full year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Avg age menopause

A

51

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Post-menopause is used to describe

A

All the time following 1 full year of cessation of menses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CC-EPT vs CS-EPT

A

CC-EPT - continuous combined EPT; daily dosing both estrogen and progestogen

CS-EPT - continuous/sequential EPT; daily estrogen and cyclic progestogen (14 days month or 3 days on 3 days off)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bio-identical HT options

A

Compounding pharmacy: bi-est, micronized progesterone

Pharm company: estradiol (vivelle patch, estring, estrace), progesterone (prometrium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Non-bioidentical hormone options

A

From natural substance: esterified estrogens (premarin)

Synthetic: progestins (provera)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Indications for use of HT

A

Decent option for women within 10 years of menopause (or younger than 60)

Benefits outweigh risks in women with no CI

BEST indication for use:
Vasomotor instability (hot flashes)
Vaginal dryness

It NOT used for disease prevention, except in the case of osteoporosis when a pt has failed bisphosphonates (given during osteopenia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Goals of menopausal intervention

A

Sx relief/improve QOL
Minimal impact on inc risk of other disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why would a woman post hysterectomy not need an opposed progestin?

A

No uterus > no endometrial lining to protect from endometrial cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The most effective tx of menopause related vasomotor sx (diminished sleep, irritability, difficulty concentration) according to the 2017 NAMS statement is ___

A

ET with or without progestogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The most effective tx of severe sx of vulvar and vaginal atrophy (dryness, dyspareunia, atrophic vaginitis) according to the 2017 NAMS statement is ___

A

ET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is another way you can describe the vulvar and vaginal changes of menopause with more patient comfortable language?

A

Genitourinary syndrome of menopause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

If there is only vaginal sx without systemic sx what is advised?

A

Local vaginal ET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Sexual function effects of ET

A

Improved lubrication, inc blood flow and sensation

NOT supported for interest, arousal, orgasmic response, libido, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ET effects urinary tract health

A

Local ET may benefit overactive bladder and reducing UTIs (estradiol ring equivalent to oxybutynin in overactive bladder)

Systemic HT may worsen/provoke stress incontinence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Advantages HT, specifically estrogen

A

Osteoporosis
Endocrine effects
Relief of perimenopausal major depression
Relief of GU sx
Relief of perimenopausia vasomotor instability
Protective against colon CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Disadvantages HT, specifically estrogen

A

Inc risk coronary event first year
Inc CVA (stroke)
Inc cancer risk
Inc VTE risk
Can increase incontinence
Increase GB dz
If already inc TGs > can cause pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Absolute CI TO HT

A

Hx breast cancer
CHD
Previous venous thromboembolic event or stroke
Known clotting disorder
Hx heart attack, angina, coronary bypass
Active liver disease undx vaginal bleeding
Pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Relative CI to HT

A

Chronic liver disease
Heart disease
Endometrial cancer
HTN
Familial hyperlipidemia
Seizure disorder
Migraine headaches
Hx thrombophlebitis
Endometriosis
Gallbladder dz

21
Q

Complete PE for HT intake

A

Height measurement
Wt measurement
Determination of obesity index
BP
Breast exam
Abdominal exam
Pelvic exam
Rectal exam

22
Q

What are some pre-treatment assessment tools to use before HT?

A

Fasting lipid profile
Blood glucose levels
Papanicolaou test
Mammography

Demography
UA
Electrocardiography
Ultrasonography for endometrial thickness and ovarian volume
ASCVD risk score
GAIL model

23
Q

3 most important factors for determining risk vs benefit for HT

A

Age at initiation (yrs since menopause)
Dose of estrogen
Route of administration

24
Q

Before selecting a tx plan for menopause, consider:

A

General health status and age
Severity of sx
Risk for developing other dz
Risks and benefits
Lifestyle
Pt view on tx options

25
Q

Levels of intervention menopause

A

Diet, exercise, stress management
Nutritional supplementation
Botanicals
HT (moderate sx)
Other pharm (SSRIs, fosamax, lipitor) (mod and severe sx)

26
Q

Examples of bioidentical hormones

A

17b estradiol
Estrone
Estriol
Progesterone
Testosterone
DHEA

27
Q

What type of hormones do NAMS, ACOG, and endocrine society advise against?

A

Custom compounded HT from compounding pharmacy

28
Q

Advantages oral HT capsules

A

Least expensive
Easy use
Storage
Beyond use date

29
Q

Disadvantages oral HT capsules

A

First pass metabolism
Subject drug to gastric pH
Gut requires active transport of molecule
Some pt may have trouble swallowing capsules
Low absorption

30
Q

E3

A

Estriol

31
Q

E2

A

Estradiol

32
Q

E1

A

Estrone

33
Q

Estriol:estradiol ratio

A

80% estriol / 20% estradiol

34
Q

Oral estradiol lipid effects

A

Dec LDL but inc atherogenicity (inc in oxidized LDL)
Inc HDL
Inc triglyceride
Inc Serum amyloid A (associated with inflammation)

35
Q

Oral estradiol CV risks

A

Increased CRP production in liver
Dec IGF1
Dec Activated protein C
Dec Antithrombin III

36
Q

Oral progesterone caps downsides

A

Rapid clearance and poor bioavailability

37
Q

Benefits oral testosterone

A

Sexual function
Inc energy
Improve memory
Improves mood
Improves concentration
Inc muscle strength

38
Q

Side effects and cautions oral testosterone

A

Acne
Hair thinning
Irritability
Raise LDL and TGs
Lowers HDL
Can convert to estrogen in body and have same risks

39
Q

Advantages sublingual/buccal dosing HT

A

Rapid absorption
Dec first pass metabolism
Bypasses gastric system
Removal of dosage form if needed

40
Q

Disadvantage sublingual/buccal dosing HT

A

Disadvantage sublingual/buccal dosing
Interference with saliva testing
Still will be oral administration from swallowing dose
Taste
Can’t confer endometrial protection with sublingual progesterone

41
Q

Transdermal HT advantages

A

Easy to use
Avoids first pass metabolism
Avoids gut metabolism
With patches, quick removal of patch removes therapy
Adjustable dosages

42
Q

Transdermal HT disadvantages

A

Dose variability
Compliance

43
Q

Dr Ashney’s most common rx ideas menopause

A

All women with uterus get estrogen AND a progesterone

Women with insurance - vivelle dot, and if she has uterus prometrium
Atrophic vaginitis or GSM - E3

44
Q

For premature menopause, when should you re-evaluate continued estrogen?

A

Age 51

45
Q

When should you consider stopping estrogen replacement with progesterone?

A

After 3-5 years of use

46
Q

When should you consider stopping estrogen replacement without progesterone?

A

After 7 years of use

47
Q

How should you discontinue HT?

A

Slow taper over 2-3 mo to reduce withdrawal effects

48
Q

Estrogen withdrawal effects

A

Irregular vaginal bleeding or spotting
Hot flushes